Our results indicate that loss of C19orf10 leads to significantly change in cell malignant behaviors, such as in vitro proliferation, migration, invasion, and in vivo overgrowth of the carcinoma xenografts derived from SW780 cells. The gene discussed is MYDGF; the disease is carcinoma.